These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 29697929

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer.
    Moon DG, Cheon J, Kim JJ, Yoon DK, Koh SK.
    Int J Urol; 1999 Sep; 6(9):455-62. PubMed ID: 10510891
    [Abstract] [Full Text] [Related]

  • 3. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
    Aksoy Y, Oral A, Aksoy H, Demirel A, Akcay F.
    Ann Clin Lab Sci; 2003 Sep; 33(3):320-3. PubMed ID: 12956448
    [Abstract] [Full Text] [Related]

  • 4. Prostate-specific antigen adjusted for the transition zone volume as a second screening test: a prospective study of 248 cases.
    Kang SH, Bae JH, Park HS, Yoon DK, Moon DG, Kim JJ, Cheon J.
    Int J Urol; 2006 Jul; 13(7):910-4. PubMed ID: 16882054
    [Abstract] [Full Text] [Related]

  • 5. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC, Marberger M.
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
    Akduman B, Alkibay T, Tuncel A, Bozkirli I.
    Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml].
    Janane A, Hajji F, Ismail T, Jawad C, Elondo JC, Dakka Y, Ghadouane M, Ameur A, Abbar M, Albouzidi A.
    Actas Urol Esp; 2012 Feb; 36(2):93-8. PubMed ID: 22188752
    [Abstract] [Full Text] [Related]

  • 10. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
    Djavan B, Remzi M, Zlotta AR, Ravery V, Hammerer P, Reissigl A, Dobronski P, Kaisary A, Marberger M.
    Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of value of free-to total prostate specific antigen, prostate specific antigen density and prostate specific antigen density of transition zone for diagnosis of prostate cancer in patients with a PSA level of 4.1-10 ng/ml].
    Fujinami K, Miura T, Takizawa A, Osada Y, Kawakami S.
    Nihon Hinyokika Gakkai Zasshi; 2005 May; 96(4):475-9. PubMed ID: 15948407
    [Abstract] [Full Text] [Related]

  • 12. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
    Kubota Y, Kamei S, Nakano M, Ehara H, Deguchi T, Tanaka O.
    Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
    [Abstract] [Full Text] [Related]

  • 13. Prospective evaluation of prostate cancer detection by prostate-specific antigen-related parameters.
    Egawa S, Suyama K, Takashima R, Mizoguchi H, Kuwao S, Baba S.
    Int J Urol; 1999 Oct; 6(10):493-501. PubMed ID: 10533900
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Optimum PSA reflex-range.
    Benecchi L.
    Arch Ital Urol Androl; 2006 Jun; 78(2):44-8. PubMed ID: 16929601
    [Abstract] [Full Text] [Related]

  • 16. Combination and multivariate analysis of PSA-based parameters for prostate cancer prediction.
    Djavan B, Remzi M, Zlotta AR, Seitz C, Wolfram R, Hruby S, Bursa B, Schulman CC, Marberger M.
    Tech Urol; 1999 Jun; 5(2):71-6. PubMed ID: 10458658
    [Abstract] [Full Text] [Related]

  • 17. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.
    Sheikh M, Al-Saeed O, Kehinde EO, Sinan T, Anim JT, Ali Y.
    Int Urol Nephrol; 2005 Jun; 37(4):721-6. PubMed ID: 16362587
    [Abstract] [Full Text] [Related]

  • 18. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
    Martínez-Piñeiro L, Tabernero A, Contreras T, Madero R, Lozano D, López-Tello J, Alonso-Dorrego JM, Picazo ML, González Gancedo P, Martínez-Piñeiro JA, de La Peña JJ.
    Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.
    MacAskill F, Lee SM, Eldred-Evans D, Wulaningsih W, Popert R, Wolfe K, Van Hemelrijck M, Rottenberg G, Liyanage SH, Acher P.
    Int Urol Nephrol; 2017 Aug; 49(8):1335-1342. PubMed ID: 28477301
    [Abstract] [Full Text] [Related]

  • 20. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
    Bretton PR, Evans WP, Borden JD, Castellanos RD.
    Cancer; 1994 Dec 01; 74(11):2991-5. PubMed ID: 7525040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.